SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-014080
Filing Date
2011-03-10
Accepted
2011-03-10 17:26:25
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v214147_10k.htm 10-K 1493473
2 EX-10.10 v214147_ex10-10.htm EX-10.10 25634
3 EX-10.11 v214147_ex10-11.htm EX-10.11 76777
4 EX-10.12 v214147_ex10-12.htm EX-10.12 15310
5 EX-23.1 v214147_ex23-1.htm EX-23.1 4099
6 EX-23.2 v214147_ex23-2.htm EX-23.2 4101
7 EX-31.1 v214147_ex31-1.htm EX-31.1 16654
8 EX-31.2 v214147_ex31-2.htm EX-31.2 16445
9 EX-32.1 v214147_ex32-1.htm EX-32.1 5722
10 EX-32.2 v214147_ex32-2.htm EX-32.2 5721
  Complete submission text file 0001144204-11-014080.txt   1665058
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22245 | Film No.: 11679494
SIC: 2834 Pharmaceutical Preparations